Stoke Therapeutics Inc. (STOK)

STOK trades at $25.56, 2.2% above the near-term max pain of $25 expiring Oct 17, 2025 (13 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($12.5-$25), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for STOK shows a downward trend from 25 to 12.5, indicating bearish sentiment or hedging activity. The 63% spread signals divergent expectations across timeframes. Most levels below 25.56 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.